OsPsyCOVID: Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak

• Sponsor: University Hospital, Lille (Other)
• Overall Status: Completed
• CT.gov ID: NCT04351633
• Collaborator: (none)
• Enrollment: 52
• Location: 1
• Actual Duration (Days): 7
• Patients Per Site Per Month: 226.1

Study Details

Study Description

Brief Summary

In the context of quarantine with COVID-19, we wish to study the experience and psychological impact in adult patients living with osteoporosis.

Condition or Disease	Intervention/Treatment	Phase
Sars-CoV2; Osteoporosis	Other: questionnaire assesment

Study Design

• Study Type: Observational
• Actual Enrollment: 52 participants
• Observational Model: Family-Based
• Time Perspective: Cross-Sectional
• Official Title: Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak
• Actual Study Start Date: Apr 23, 2020
• Actual Primary Completion Date: Apr 30, 2020
• Actual Study Completion Date: Apr 30, 2020

Arms and Interventions

Arm	Intervention/Treatment
osteoporosis patient	Other: questionnaire assesment; questionnaire assesment

Outcome Measures

Primary Outcome Measures

1. percentage of patient with feeling of disabilities [maximum 1 week from baseline on]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patient with osteoporosis

• Patient in confinement

• Patient with sufficient understanding of the French language

Exclusion Criteria:

• Non adult patient

• patient without quarantine

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hopital Roger Salengro, CHU Lille	Lille		France	59037

Sponsors and Collaborators

• University Hospital, Lille

Investigators

• Principal Investigator: Bernard Cortet, MD,PhD, University Hospital, Lille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University Hospital, Lille
• ClinicalTrials.gov Identifier: NCT04351633
• Other Study ID Numbers: 2020_31; 2020-A00911-38
• First Posted: Apr 17, 2020
• Last Update Posted: Dec 11, 2020
• Last Verified: May 1, 2020

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by University Hospital, Lille: Psychological impact; COVID-19
• Additional relevant MeSH terms: COVID-19; Osteoporosis

Study Results

No Results Posted as of Dec 11, 2020